EMV Capital

EMV Capital is an award-winning VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors in the UK and internationally. EMV Capital develops unique investment strategies for each portfolio company, drawing on its EIS fund and extensive network of private investors, family offices, institutions, and corporate VCs. Delivery and successful execution of these investment strategies enables innovative portfolio companies to raise funding to drive transformational growth. EMV Capital is a wholly owned subsidiary of NetScientific plc (AIM:NSCI), a life sciences and technology commercialisation and investment group. EMV Capital has a multi-disciplinary team of specialist investors, portfolio managers, capital raisers, legal, finance, marketing and support staff. The company is focused on primary and secondary investments, through debt and/or equity.

Ian Cooke

Venture Partner

Stephen Crowe

CFO

Ed Hooper

Director

Charles Laughton

Associate Director, Corporate Finance

Harry Miller

Investment Associate

Igor Turevsky

Venture Partner

Mark Williams

Venture Partner

23 past transactions

Q-Bot

Venture Round in 2022
Q-BOT Ltd, a Wandsworth, London, UK-based developer of a robotics platform that can access, survey, evaluate and apply treatments in a wide range of industries and applications. The company is funded through a combination of government grants, private investment and sales revenue, and has been supported by Climate-KIC, The Technology Strategy Board and The Department for Energy and Climate Change.

Martlet Capital

Venture Round in 2021
Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. They seek to support entrepreneurs with value beyond capital. They have experience of helping companies scale from first-round through to exit. Visit their website to take a look at how we work and their investment focus.

EpiBone

Venture Round in 2021
EpiBone is a pioneering regenerative medicine company at the forefront of bone and cartilage repair. Leveraging the power of stem cells, biomimicry, and 3D fabrication, they are developing a pipeline of innovative products with enormous potential to revolutionize orthopedic repair. Their lead product, a living, anatomically precise 3D bone graft, completed its Phase I/IIa clinical trial in August 2023. The rest of their pipeline focuses on cartilage repair, and includes an allogeneic osteochondral plug, whose IND was approved in July 2023. Their cartilage portfolio also includes an injectable cartilage filler that was partly funded by the Department of Defense.

PointGrab

Venture Round in 2021
PointGrab Ltd. develops machine learning technology installed in optical IoT sensors for commercial Real Estate. The sensors enables Companies to better manage their real estate, increase efficiency and cut Real Estate costs, while keeping Employees' privacy and welfare. PointGrab is considered marker leader in providing occupancy and smart building features in commercial Real Estate.

SageTech

Seed Round in 2021
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost and environmental benefits for healthcare providers. SageTech has developed, prototyped, and patented systems to capture, extract and purify inhalational anaesthetic emissions, creating a circular economy for a formerly wasteful pharmaceutical product

Sofant Technologies

Venture Round in 2021
Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.

SageTech

Seed Round in 2020
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost and environmental benefits for healthcare providers. SageTech has developed, prototyped, and patented systems to capture, extract and purify inhalational anaesthetic emissions, creating a circular economy for a formerly wasteful pharmaceutical product

Sofant Technologies

Venture Round in 2020
Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.

Sofant Technologies

Venture Round in 2019
Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.

Q-Bot

Series A in 2019
Q-BOT Ltd, a Wandsworth, London, UK-based developer of a robotics platform that can access, survey, evaluate and apply treatments in a wide range of industries and applications. The company is funded through a combination of government grants, private investment and sales revenue, and has been supported by Climate-KIC, The Technology Strategy Board and The Department for Energy and Climate Change.

Vortex Biosciences

Acquisition in 2019
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from whole blood.

Wanda Health

Acquisition in 2019
Wanda Inc is a company focused on providing innovative healthcare solutions through its intelligent platform designed for Remote Patient Monitoring and Virtual Care. The company specializes in disease management programs related to cardiology, chronic diseases, and comorbidities, aiming to enhance health outcomes and elevate patient experiences. Wanda Inc's technology offers the ability to identify potential adverse events in patients with acute, chronic, and specialty diseases up to seven days in advance, allowing healthcare providers to receive timely alerts and detailed insights. This proactive approach enables clinicians to intervene early, ultimately empowering patients to take control of their health and wellbeing while also reducing the overall cost of care and improving staff wellbeing.

Vortex Biosciences

Series A in 2019
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from whole blood.

Wanda Health

Series A in 2019
Wanda Inc is a company focused on providing innovative healthcare solutions through its intelligent platform designed for Remote Patient Monitoring and Virtual Care. The company specializes in disease management programs related to cardiology, chronic diseases, and comorbidities, aiming to enhance health outcomes and elevate patient experiences. Wanda Inc's technology offers the ability to identify potential adverse events in patients with acute, chronic, and specialty diseases up to seven days in advance, allowing healthcare providers to receive timely alerts and detailed insights. This proactive approach enables clinicians to intervene early, ultimately empowering patients to take control of their health and wellbeing while also reducing the overall cost of care and improving staff wellbeing.

Insight

Series A in 2018
Insight has developed an Akinetic, all semiconductor laser: a platform technology with a step-change in performance for multiple applications including Industrial maintenance and processes monitoring for resource efficiency, LiDAR, and Medical Imaging. Laser imaging currently relies on Time-Of-Flight measurement, measuring the timing of light pulses hitting target and returning to receiver. This method has inherent limitations that has prevented 3D imaging quality improvements and application of technology within new sectors. Alternative methods require lasers to sweep across a range of frequencies, with incumbent technologies relying on kinetic technology which suffer from low speed, low durability, and susceptibility to vibration and shocks. Insight Photonics has developed a solid state all-semiconductor akinetic swept laser chip which can image faster (2-20x), with higher resolution (10x), and with higher sensitivity (10-100x) than current competitors, using Optical Coherence Technology (OCT). Akinetic operation results in greater durability and reliability than competitive OCT solutions, whilst also offering higher quality output at broad range of wavelengths. No moving or thermally operated elements allows for faster response-times and greater flexibility with software-controlled activity.

SageTech

Series A in 2018
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost and environmental benefits for healthcare providers. SageTech has developed, prototyped, and patented systems to capture, extract and purify inhalational anaesthetic emissions, creating a circular economy for a formerly wasteful pharmaceutical product

Nanotech Industrial Solutions

Venture Round in 2018
NIS produces oil additives for engine oils, oil and water formulations for metalworking fluids, industrial oils and additive formulations for greases. NIS’ patented technology releases nanostructured materials under certain physical conditions. The unique morphology significantly improves friction and wear properties, resulting in a substantial contribution of the technology to resource efficiency of heavy machinery, power plants and industrial plants.

PointGrab

Series A in 2015
PointGrab Ltd. develops machine learning technology installed in optical IoT sensors for commercial Real Estate. The sensors enables Companies to better manage their real estate, increase efficiency and cut Real Estate costs, while keeping Employees' privacy and welfare. PointGrab is considered marker leader in providing occupancy and smart building features in commercial Real Estate.

Autorose

Seed Round in 2015
Autorose develops a mobile application that helps users track the state of their car to avoid unexpected maintenance costs. It is a portfolio company of EcoMachines Ventures.

Recycling Technologies

Seed Round in 2014
Recycling Technologies offers solutions to help customers achieve financial gains through turning mixed plastic waste into a valuable resource. It has developed a machine – the RT7000 – to convert plastic waste into Plaxx®, a chemical feedstock for plastic production. The machine is compact and modular, and designed to integrate with existing waste sites to significantly increase recycling capacity.

Q-Bot

Seed Round in 2014
Q-BOT Ltd, a Wandsworth, London, UK-based developer of a robotics platform that can access, survey, evaluate and apply treatments in a wide range of industries and applications. The company is funded through a combination of government grants, private investment and sales revenue, and has been supported by Climate-KIC, The Technology Strategy Board and The Department for Energy and Climate Change.

Power Drive Efficiency

Seed Round in 2014
Power Drive Efficiency creates energy efficiency equipment throughout the electric power system with integrated Internet of Things solutions. PDE's solutions are built to be fully compatible with equipment old and new.

Rotary EcoMachines

Seed Round in 2014
Rotary EcoMachines Limited develops and manufactures rotary piston combustion engines. Its piston engines are used in the automotive industry, pumps, concentrated solar power applications, and unmanned aerial vehicles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.